Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (8125)
All Articles published online
|
Publishing Process of This Article
|
Dec 21, 2015 (publication date) through Jun 10, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Yang F, Lv LZ, Cai QC, Jiang Y. Potential roles of EZH2, Bmi-1 and miR-203 in cell proliferation and invasion in hepatocellular carcinoma cell line Hep3B. World J Gastroenterol 2015; 21(47): 13268-13276 [PMID: 26715809 DOI: 10.3748/wjg.v21.i47.13268] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v21/i47/13268.htm |
| Number | Citing Articles |
| 1 |
Bin Huang, Manping Huang, Qin Li. MiR-137 suppresses migration and invasion by targeting EZH2-STAT3 signaling in human hepatocellular carcinoma. Pathology - Research and Practice 2018; 214(12): 1980 doi: 10.1016/j.prp.2018.08.005
|
| 2 |
Xiao‐Bo Zheng, Xiao‐Bo Chen, Liang‐Liang Xu, Ming Zhang, Lei Feng, Peng‐Sheng Yi, Jian‐Wei Tang, Ming‐Qing Xu. miR‐203 inhibits augmented proliferation and metastasis of hepatocellular carcinoma residual in the promoted regenerating liver. Cancer Science 2017; 108(3): 338 doi: 10.1111/cas.13167
|
| 3 |
Li Fu, Bing Han, Yang Zhou, Jie Ren, Wenzhi Cao, Gopal Patel, Guoyin Kai, Jun Zhang. The Anticancer Properties of Tanshinones and the Pharmacological Effects of Their Active Ingredients. Frontiers in Pharmacology 2020; 11 doi: 10.3389/fphar.2020.00193
|
| 4 |
Jie Xu, Lin Li, Pengfei Shi, Hongjuan Cui, Liqun Yang. The Crucial Roles of Bmi-1 in Cancer: Implications in Pathogenesis, Metastasis, Drug Resistance, and Targeted Therapies. International Journal of Molecular Sciences 2022; 23(15): 8231 doi: 10.3390/ijms23158231
|
| 5 |
Simona Todisco, Paolo Convertini, Vito Iacobazzi, Vittoria Infantino. TCA Cycle Rewiring as Emerging Metabolic Signature of Hepatocellular Carcinoma. Cancers 2019; 12(1): 68 doi: 10.3390/cancers12010068
|
| 6 |
Qiaofang Li, Shuguang Li, Xingxiao Yang, Xueyuan Zhang, Chunyang Song, Shuchai Zhu. Association between RNF2+P‑AKT expression in pretreatment biopsy specimens, and poor survival following radiotherapy in patients with esophageal squamous cell carcinoma. Oncology Letters 2019; doi: 10.3892/ol.2019.10727
|
| 7 |
Ru Wang, Hengwei Fan, Ming Sun, Zhongwei Lv, Wanwan Yi. Roles of BMI1 in the Initiation, Progression, and Treatment of Hepatocellular Carcinoma. Technology in Cancer Research & Treatment 2022; 21: 153303382110706 doi: 10.1177/15330338211070689
|
| 8 |
Joanna Szczepanek, Andrzej Tretyn. MicroRNA-Mediated Regulation of Histone-Modifying Enzymes in Cancer: Mechanisms and Therapeutic Implications. Biomolecules 2023; 13(11): 1590 doi: 10.3390/biom13111590
|
| 9 |
Antonella Muscella, Erika Stefàno, Luigi De Bellis, Eliana Nutricati, Carmine Negro, Santo Marsigliante. Antitumor and antimigration effects of Salvia clandestina L. extract on osteosarcoma cells. Annals of the New York Academy of Sciences 2021; 1500(1): 34 doi: 10.1111/nyas.14601
|
| 10 |
Kurt Sartorius, Ping An, Cheryl Winkler, Anil Chuturgoon, Xiaodong Li, Julia Makarova, Anna Kramvis. The Epigenetic Modulation of Cancer and Immune Pathways in Hepatitis B Virus-Associated Hepatocellular Carcinoma: The Influence of HBx and miRNA Dysregulation. Frontiers in Immunology 2021; 12 doi: 10.3389/fimmu.2021.661204
|
| 11 |
Junlong Zhao, Huichen Li, Shoujie Zhao, Enxin Wang, Jun Zhu, Dayun Feng, Yejing Zhu, Weijia Dou, Qingling Fan, Jie Hu, Lintao Jia, Lei Liu. Epigenetic silencing of miR-144/451a cluster contributes to HCC progression via paracrine HGF/MIF-mediated TAM remodeling. Molecular Cancer 2021; 20(1) doi: 10.1186/s12943-021-01343-5
|
| 12 |
Fang Qian, Wei Kong, Shuaiqun Wang, Kai Wei. Predicting the prognosis of hepatocellular carcinoma based on the interaction between pyroptosis, apoptosis, and necroptosis. Clinical and Experimental Medicine 2022; 23(6): 2087 doi: 10.1007/s10238-022-00910-4
|
| 13 |
Tae-Su Han, Hyun Seung Ban, Keun Hur, Hyun-Soo Cho. The Epigenetic Regulation of HCC Metastasis. International Journal of Molecular Sciences 2018; 19(12): 3978 doi: 10.3390/ijms19123978
|
| 14 |
Yiping Wen, Jing Cai, Yaya Hou, Zaiju Huang, Zehua Wang. Role of EZH2 in cancer stem cells: from biological insight to a therapeutic target. Oncotarget 2017; 8(23): 37974 doi: 10.18632/oncotarget.16467
|
| 15 |
Maria M. Simile, Graziella Peitta, Maria L. Tomasi, Stefania Brozzetti, Claudio F. Feo, Alberto Porcu, Antonio Cigliano, Diego F. Calvisi, Francesco Feo, Rosa M. Pascale. MicroRNA-203 impacts on the growth, aggressiveness and prognosis of hepatocellular carcinoma by targeting MAT2A and MAT2B genes. Oncotarget 2019; 10(29): 2835 doi: 10.18632/oncotarget.26838
|